NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 34 filers reported holding NRX PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88 | -46.3% | 339 | 0.0% | 0.00% | – |
| Q2 2023 | $164 | – | 339 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 339 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 339 | -100.0% | 0.00% | – |
| Q3 2022 | $650,000 | +64900.0% | 878,961 | +44882.7% | 0.00% | – |
| Q2 2022 | $1,000 | -94.1% | 1,954 | -71.9% | 0.00% | – |
| Q1 2022 | $17,000 | -32.0% | 6,952 | +34.1% | 0.00% | – |
| Q4 2021 | $25,000 | +1150.0% | 5,184 | +2345.3% | 0.00% | – |
| Q3 2021 | $2,000 | – | 212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 325,000 | $84,500 | 0.06% |
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $16,455 | 0.00% |
| XTX Topco Ltd | 11,809 | $3,070 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $4,758 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,700 | $41,782 | 0.00% |
| UBS Group AG | 1,210 | $315 | 0.00% |
| NewEdge Advisors, LLC | 7,125 | $1,853 | 0.00% |
| Lido Advisors, LLC | 13,000 | $3,380 | 0.00% |
| OSAIC HOLDINGS, INC. | 11,125 | $2,891 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,379 | $1,399 | 0.00% |